TB-500 is not FDA-approved and is banned by WADA
Patients may experience flushing, abdominal pain, brain fog, anxiety, and neuropathic painsymptoms often linked to overactive immune and nervous system communication
Another innovative approach involves injectable depots, such as hydrogels developed at Stanford University, which incorporate GLP-1 analogues for sustained release over approximately 4 months following a single injection
Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome
Parenteral therapies are likely to keep strong adoption as injectable formats already have mature prescribing and device systems
Learn more IV Therapy FAQ What types of IV therapy does PMC offer